Expert Opinion on Pharmacotherapy, Volume 21, Issue 1 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 21, Issue 1 (2020)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Volume 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Selecting dopamine depleters for hyperkinetic movement disorders: how do we choose?
Laszlo Szpisjak, Andras Salamon, Denes Zadori, Peter Klivenyi & Laszlo Vecsei
Pages: 1-4
Published online: 30 Oct 2019
First Page PreviewforSelecting dopamine depleters for hyperkinetic movement disorders: how do we choose? | Full Text | References | PDF (386 KB) | EPUB
  • 1394 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Recommendations for the pharmacological management of irritability and aggression in conduct disorder patients
Simone Pisano & Gabriele Masi
Pages: 5-7
Published online: 30 Oct 2019
First Page PreviewforRecommendations for the pharmacological management of irritability and aggression in conduct disorder patients | Full Text | References | PDF (315.1 KB) | EPUB
  • 5868 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder
Joanna Kryst, Paweł Kawalec & Andrzej Pilc
Pages: 9-20
Published online: 30 Oct 2019
AbstractforEfficacy and safety of intranasal esketamine for the treatment of major depressive disorder | Full Text | References | PDF (899.5 KB) | EPUB
  • 1806 Views
  • 44 CrossRef citations
  • 0Altmetric
Article
An up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity
Beverly G. Tchang, Brittany Abel, Christina Zecca, Katherine H. Saunders & Alpana P. Shukla
Pages: 21-28
Published online: 06 Nov 2019
AbstractforAn up-to-date evaluation of lorcaserin hydrochloride for the treatment of obesity | Full Text | References | PDF (662.4 KB) | EPUB
  • 404 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma
Fortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, Cirino Botta, Mamdouh Skafi, Mohammed Abu-Rayyan, Moien Atrash, Sara Galimberti, Lucio Morabito, Hamdi Al-Janazreh, Massimo Martino, Giovanna Cutrona & Massimo Gentile
Pages: 29-38
Published online: 18 Nov 2019
AbstractforAn in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma | Full Text | References | PDF (924.2 KB) | EPUB
  • 591 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
Sapna Sinha, Daniel Lee, Natasha N. Kolomeyer, Jonathan S. Myers & Reza Razeghinejad
Pages: 39-45
Published online: 30 Oct 2019
AbstractforFixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension | Full Text | References | PDF (813.3 KB) | EPUB
  • 345 Views
  • 8 CrossRef citations
  • 0Altmetric

Review

Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough?
Paola Bozzatello, Paola Rocca, Maria Laura De Rosa & Silvio Bellino
Pages: 47-61
Published online: 06 Nov 2019
AbstractforCurrent and emerging medications for borderline personality disorder: is pharmacotherapy alone enough? | Full Text | References | PDF (1.1 MB) | EPUB
  • 2719 Views
  • 20 CrossRef citations
  • 0Altmetric
Current and emerging pharmacological approaches for treating diarrhea-predominant irritable bowel syndrome
Akhil Munjal, Bhavtosh Dedania & Brooks D. Cash
Pages: 63-71
Published online: 18 Nov 2019
AbstractforCurrent and emerging pharmacological approaches for treating diarrhea-predominant irritable bowel syndrome | Full Text | References | PDF (718.8 KB) | EPUB
  • 321 Views
  • 2 CrossRef citations
  • 0Altmetric
Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome
Karolina Niewinna, Anna Zielińska & Jakub Fichna
Pages: 73-84
Published online: 14 Nov 2019
AbstractforRecent advances in the pharmacological management of constipation predominant irritable bowel syndrome | Full Text | References | PDF (1 MB) | EPUB
  • 389 Views
  • 8 CrossRef citations
  • 0Altmetric
Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium
Mohamed Abou Chakra, Athanasios E. Dellis, Athanasios G. Papatsoris & Mohamad Moussa
Pages: 85-96
Published online: 12 Nov 2019
AbstractforEstablished and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium | Full Text | References | PDF (917.7 KB) | EPUB
  • 404 Views
  • 11 CrossRef citations
  • 0Altmetric
Bacterial meningitis: new treatment options to reduce the risk of brain damage
Nicola Principi & Susanna Esposito
Pages: 97-105
Published online: 01 Nov 2019
AbstractforBacterial meningitis: new treatment options to reduce the risk of brain damage | Full Text | References | PDF (821.5 KB) | EPUB
  • 724 Views
  • 6 CrossRef citations
  • 0Altmetric
Recent developments in pharmacotherapy for hypertriglyceridemia: what’s the current state of the art?
Matilda Florentin, Michael S Kostapanos, Panagiotis Anagnostis & George Liamis
Pages: 107-120
Published online: 18 Nov 2019
AbstractforRecent developments in pharmacotherapy for hypertriglyceridemia: what’s the current state of the art? | Full Text | References | PDF (1.1 MB) | EPUB
  • 399 Views
  • 8 CrossRef citations
  • 0Altmetric

Original Research

Article
Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin
Tomoko Hayashi, Hiroki Murayama, Yohei Shinfuku, Tomoko Taniguchi, Isao Tsumiyama & Naotsugu Oyama
Pages: 121-130
Published online: 05 Nov 2019
AbstractforSafety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin | Full Text | References | PDF (935.5 KB) | EPUB | Supplemental
  • 4603 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?
Prathima Gogineni et al.
Review Article | Published online: 22 May 2024
Open Access
Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease
Eiji Higashihara et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles